Recent advances in the understanding of cancer have led to more personalized therapies, such as drugs that target particular proteins and tests that analyze gene expression patterns in tumors to predict a patient's response to therapy. Researchers at Moffitt Cancer Center in Tampa, Florida, have contributed to these advances by developing the first test that analyzes the sensitivity of tumors to radiation therapy. They discovered that colon cancer metastases have varying sensitivity to radiotherapy based on their anatomic location.

British-based MR Solutions has introduced the world’s first commercial, superconducting, preclinical magnetic resonance imaging (MRI) scanner that does not require the traditional liquid helium cooling jacket. The introduction follows a call in June by anaesthetist Tom Dolphin of the British Medical Association’s junior doctors’ committee for a ban on using helium in balloons, as there is a shortage for MRI scanners.

4WEB Medical, provider of 3-D printed orthopedic implants, announced its first Australian patient-specific implant surgery. Supported by 4WEB's Australian partner, LifeHealthcare, the 4WEB patient-specific segmental bone defect procedure was completed the week of July 20 in Brisbane, Australia.

August 6, 2015 — IBM announced that its Watson Health Cloud will gain the ability to “see” following the planned ...